Sawicki P T, Dähne R, Bender R, Berger M
Medical Department of Metabolic Diseases and Nutrition, Heinrich-Heine University, Düsseldorf, Germany.
Diabetologia. 1996 Jan;39(1):77-81. doi: 10.1007/BF00400416.
Patients with diabetic nephropathy face an increased risk of dying due to cardiac causes. The aim of this follow-up trial was to describe the association between the length of the QT interval, as a marker of myocardial electrical stability, and the risk of death in insulin-dependent (IDDM) diabetic patients with overt diabetic nephropathy. A consecutive sample of 85 IDDM patients with overt diabetic nephropathy (i.e. persistent proteinuria > or = 500 mg/24 h) were followed-up until death or for a period of 5-13 years. QT intervals were measured once at baseline in a 12-lead ECG and corrected for heart rate (QTc). During the follow-up period 33 patients (39%) died. In the Cox proportional hazards model independent predictors of death were age (p = 0.0007), the length of the maximum QTc period (p = 0.0049), presence of autonomic neuropathy (p = 0.0068), diabetes duration (p = 0.0163) and RR variation (p = 0.0395). In conclusion, in nephropathic IDDM patients QT prolongation is associated with an increased mortality risk which is independent of the presence of autonomic neuropathy. Further studies are needed to determine whether this risk might be reduced by therapeutic interventions.
糖尿病肾病患者因心脏原因死亡的风险增加。这项随访试验的目的是描述作为心肌电稳定性标志物的QT间期长度与显性糖尿病肾病的胰岛素依赖型(IDDM)糖尿病患者死亡风险之间的关联。对85例显性糖尿病肾病的IDDM患者(即持续性蛋白尿≥500mg/24小时)进行连续抽样,随访至死亡或长达5 - 13年。在基线时通过12导联心电图测量一次QT间期,并根据心率进行校正(QTc)。在随访期间,33例患者(39%)死亡。在Cox比例风险模型中,死亡的独立预测因素为年龄(p = 0.0007)、最大QTc间期长度(p = 0.0049)、自主神经病变的存在(p = 0.0068)、糖尿病病程(p = 0.0163)和RR变异(p = 0.0395)。总之,在肾病性IDDM患者中,QT延长与死亡风险增加相关,这与自主神经病变的存在无关。需要进一步研究以确定这种风险是否可以通过治疗干预降低。